Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of the American Society of Nephrology

• Publication date

  2015-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1681/ASN.2014040325PMID 25475745PMCID PMC4413766
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fibroblast Growth Factor–23 and Cardiac Structure and Function

  2014cited by this paper
• Loss of Klotho contributes to kidney injury by derepression of Wnt/β-catenin signaling.

  2013cited by this paper
• Serum level of soluble (pro)renin receptor is modulated in chronic kidney disease

  2013cited by this paper
• Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism

  2013cited by this paper
• Laboratory aspects of circulating α-Klotho.

  2013cited by this paper
• Vascular calcification and hypertension: Cause and effect

  2012cited by this paper
• Cardiorenal Syndrome: The Emerging Role of Protein-Bound Uremic Toxins

  2012cited by this paper
• Fibroblast growth factor 23: friend or foe in uremia?

  2012cited by this paper
• Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart

  2012cited by this paper
• FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality.

  2012cited by this paper
• UPDATE ON FIBROBLAST GROWTH FACTOR 23 IN CHRONIC KIDNEY DISEASE

  2012cited by this paper
• The emerging role of Klotho in clinical nephrology.

  2012cited by this paper
• Uremic cardiomyopathy and insulin resistance: a critical role for akt?

  2011cited by this paper
• Hypertension, left ventricular hypertrophy and chronic kidney disease

  2011cited by this paper
• Klotho deficiency causes vascular calcification in chronic kidney disease.

  2011cited by this paper
• FGF23 induces left ventricular hypertrophy.

  2011cited by this paper
• Downregulation of NCC and NKCC2 cotransporters by kidney-specific WNK1 revealed by gene disruption and transgenic mouse models.

  2011cited by this paper
• Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule

  2010cited by this paper
• TRP-ing up Heart and Vessels: Canonical Transient Receptor Potential Channels and Cardiovascular Disease

  2010cited by this paper
• Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease

  2009cited by this paper
• The FGF23–Klotho axis: endocrine regulation of phosphate homeostasis

  2009cited by this paper
• Left ventricular mass in chronic kidney disease and ESRD.

  2009cited by this paper
• Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1

  2008cited by this paper
• Partial nephrectomy as a model for uremic cardiomyopathy in the mouse.

  2008cited by this paper
• NON‐CORONARY HEART DISEASE IN DIALYSIS PATIENTS: Hypertrophy and Fibrosis in the Cardiomyopathy of Uremia—Beyond Coronary Heart Disease

  2008cited by this paper
• Prevalence of chronic kidney disease in the United States.

  2007cited by this paper
• Augmented Wnt Signaling in a Mammalian Model of Accelerated Aging

  2007cited by this paper
• Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.

  2007cited by this paper
• The Antisenescence Protein Klotho Is Necessary for FGF23-Induced Phosphaturia Klotho Converts Canonical FGF Receptor into a Specific Receptor for FGF23.Nature 444: 770-774, 2006.

  2007cited by this paper
• Faculty Opinions recommendation of alpha-Klotho as a regulator of calcium homeostasis.

  2007cited by this paper
• α-Klotho as a Regulator of Calcium Homeostasis

  2007cited by this paper
• Regulation of Fibroblast Growth Factor-23 Signaling by Klotho*

  2006cited by this paper
• Klotho converts canonical FGF receptor into a specific receptor for FGF23

  2006cited by this paper
• TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling.

  2006cited by this paper
• Faculty Opinions recommendation of The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel.

  2006cited by this paper
• Serum phosphate levels and mortality risk among people with chronic kidney disease.

  2005cited by this paper
• The ß-Glucuronidase Klotho Hydrolyzes and Activates the TRPV5 Channel

  2005cited by this paper
• Suppression of Aging in Mice by the Hormone Klotho

  2005cited by this paper
• Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.

  2004cited by this paper
• Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

  2004cited by this paper
• Hypertrophy of the heart: a new therapeutic target?

  2004cited by this paper
• Secreted Klotho protein in sera and CSF: implication for post‐translational cleavage in release of Klotho protein from cell membrane

  2004cited by this paper
• Control of Cardiac Growth and Function by Calcineurin Signaling*

  2003cited by this paper
• Mediation of Unusually High Concentrations of 1,25-Dihydroxyvitamin D in Homozygous klotho Mutant Mice by Increased Expression of Renal 1α-Hydroxylase Gene.

  2002cited by this paper
• Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1alpha-hydroxylase gene.

  2002cited by this paper
• The progression of aging in klotho mutant mice can be modified by dietary phosphorus and zinc.

  2001cited by this paper
• Severely reduced production of klotho in human chronic renal failure kidney.

  2001cited by this paper
• Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

  2000cited by this paper
• Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.

  1998cited by this paper
• Mutation of the mouse klotho gene leads to a syndrome resembling ageing

  1997cited by this paper

• Cardiorenal and Metabolic Dimensions of Cardiomyopathies and Heart Failure: Focus on SGLT2i, GLP1-RA, and ns-MRA

  2026cites this paper
• Fibroblast Growth Factor-23 and Cardiovascular Disease in Patients With Chronic Kidney Disease.

  2026cites this paper
• Klotho Suppresses Indoxyl Sulfate-Mediated Apoptosis in Human Kidney Proximal Tubular (HK-2) Cells through Modulating the AKT/Nrf2 Mechanism

  2025cites this paper
• Assessment of Cardiovascular Risk and Examination of Blood Klotho Levels in Patients with Ankylosing Spondylitis

  2025cites this paper
• Non-Invasive Assessment of Vascular Damage Through Pulse Wave Velocity and Superb Microvascular Imaging in Pre-Dialysis Patients

  2025cites this paper
• Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).

  2025cites this paper
• Renal-Cardiac Crosstalk in the Pathogenesis and Progression of Heart Failure

  2025cites this paper
• Klotho is cardioprotective in the mdx mouse model of Duchenne muscular dystrophy.

  2025cites this paper
• Klotho’s Impact on Cardiovascular Disease, Fractures, and Mortality in Hemodialysis

  2025cites this paper
• Interaction Effect of Estimated Pulse Wave Velocity and Serum Klotho Level on Chronic Kidney Disease

  2025cites this paper
• Growth hormone treatment associates with improved circulating anti-aging protein Klotho and reduced arterial stiffness in children with CKD

  2025cites this paper
• Conformational landscape of soluble α-klotho revealed by cryogenic electron microscopy

  2025cites this paper
• Involvement of α-klotho in growth hormone (GH) signaling

  2024cites this paper
• Serum klotho as a novel biomarker for metabolic syndrome: findings from a large national cohort

  2024cites this paper
• U-shaped association between serum Klotho and all-cause mortality in US cardiovascular patients: a prospective cohort study

  2024cites this paper
• Investigation of α-Klotho Concentrations in Serum of Cats Affected by Hypertrophic Cardiomyopathy

  2024cites this paper
• Dialogues between basic and clinical researchers: hyperphosphatemia

  2024cites this paper
• Klotho plasma levels are an independent predictor of mortality in women with acute coronary syndrome

  2024cites this paper
• Beneficial effects of physical exercise on the osteo-renal Klotho-FGF-23 axis in Chronic Kidney Disease: A systematic review with meta-analysis

  2024cites this paper
• Sex differences in mortality risk and U-shaped relationship with klotho levels: A long-term cohort study.

  2024cites this paper
• Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease–Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows

  2024cites this paper
• AMP‐dependent kinase stimulates the expression of αKlotho

  2024cites this paper
• α-Klotho is associated with cardiovascular and all-cause mortality in patients with stage 3b and 4 chronic kidney disease (CKD): a long-term prospective cohort study

  2024cites this paper
• Klotho, an Anti-Aging Protein with Significant Potential in Regenerative Medicine

  2024cites this paper
• The optimal cut-off values of Klotho for predicting all-cause and cardiovascular mortality among chronic kidney disease: results from NHANES

  2024cites this paper
• Conformational landscape of soluble α-klotho revealed by cryogenic electron microscopy

  2024cites this paper
• Klotho enhances diastolic function in aged hearts through Sirt1-mediated pathways

  2024cites this paper
• C-Terminal Fragment of Fibroblast Growth Factor (FGF)-23 Improves Heart Function in Murine Models of High intact FGF23.

  2024cites this paper
• Lipid Toxicity in the Cardiovascular-Kidney-Metabolic Syndrome (CKMS)

  2024cites this paper
• Fibroblast Growth Factor 23 and Risk of Heart Failure Subtype: The CRIC (Chronic Renal Insufficiency Cohort) Study

  2023influential citation
• The authors reply.

  2023cites this paper
• Klotho and lean mass as novel cardiovascular risk factors in hemodialysis patients

  2023cites this paper
• Role of Chronic Kidney Disease (CKD)–Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD

  2023cites this paper
• FGF23 in Chronic Kidney Disease: Bridging the Heart and Anemia

  2023influential citation
• Implications of uremic cardiomyopathy for the practicing clinician: an educational review

  2023cites this paper
• Fibroblast growth factor 23, klotho and heparin

  2023cites this paper
• Avaliação dos fatores de risco de aterosclerose e disfunção endotelial em pacientes com glomerulopatias primárias

  2023cites this paper
• Assessment and management of heart failure in patients with chronic kidney disease

  2023cites this paper
• Updates in the chronic kidney disease-mineral bone disorder show the role of osteocytic proteins, a potential mechanism of the bone—Vascular paradox, a therapeutic target, and a biomarker

  2023cites this paper
• Correlation between sKL and Nrf2 plasma levels and calcium oxalate urolithiasis

  2023cites this paper
• Myocardial Remodeling in Early Chronic Kidney Disease—Mineral and Bone Disorder Model with Low Bone Turnover

  2023cites this paper
• Association between soluble α-klotho and mortality risk in middle-aged and older adults

  2023cites this paper
• Assessment of atherosclerosis and endothelial dysfunction risk factors in patients with primary glomerulonephritis

  2023cites this paper
• Fibroblast Growth Factor Signaling in Development and Disease

  2023cites this paper
• Fibroblast Growth Factor 23 Bone Regulation and Downstream Hormonal Activity

  2023cites this paper
• Management of Cardiovascular Diseases in Chronic Hemodialysis Patients

  2023cites this paper
• The role of Klotho and FGF23 in cardiovascular outcomes of diabetic patients with chronic limb threatening ischemia: a prospective study

  2023cites this paper
• Klotho, Oxidative Stress, and Mitochondrial Damage in Kidney Disease

  2023cites this paper
• Cardiomyopathy in chronic kidney disease: clinical features, biomarkers and the contribution of murine models in understanding pathophysiology

  2023cites this paper
• FGF23 and klotho at the intersection of kidney and cardiovascular disease

  2023cites this paper
• Partial Genetic Deletion of Klotho Aggravates Cardiac Calcium Mishandling in Acute Kidney Injury

  2023cites this paper
• In Vivo Cardiac-specific Expression of Adenylyl Cyclase 4 Gene Protects against Klotho Deficiency-induced Heart Failure.

  2022cites this paper
• Interplay between mineral bone disorder and cardiac damage in acute kidney injury: from Ca2+ mishandling and preventive role of Klotho in mice to its potential mortality prediction in human.

  2022cites this paper
• Glucosylceramide synthase inhibition protects against cardiac hypertrophy in chronic kidney disease

  2022cites this paper
• From cardiorenal syndromes to cardionephrology: a reflection by nephrologists on renocardiac syndromes

  2022cites this paper
• Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease.

  2022cites this paper
• The serum soluble Klotho alleviates cardiac aging and regulates M2a/M2c macrophage polarization via inhibiting TLR4/Myd88/NF-κB pathway.

  2022cites this paper
• The Value of Klotho in Kidney Transplantation

  2022cites this paper
• Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations

  2022cites this paper
• Phosphate and Cellular Senescence.

  2022cites this paper
• Pro-oxidative priming but maintained cardiac function in a broad spectrum of murine models of chronic kidney disease

  2022cites this paper
• The regulation of FGF23 under physiological and pathophysiological conditions

  2022cites this paper
• 6-O-desulfated heparin attenuates myocardial ischemia/reperfusion injury in mice through the regulation of miR-199a-5p/klotho axis.

  2022cites this paper
• Klotho: An Emerging Factor With Ergogenic Potential

  2022cites this paper
• Prazosin improves neurogenic acute heart failure through downregulation of fibroblast growth factor 23 in rat hearts

  2022cites this paper
• The Diabetic Cardiorenal Nexus

  2022cites this paper
• Administration of α-Klotho Does Not Rescue Renal Anemia in Mice

  2022cites this paper
• Low Klotho/Fibroblast Growth Factor 23 Ratio Is an Independent Risk Factor for Renal Progression in Chronic Kidney Disease: Finding From KNOW-CKD

  2022cites this paper
• Berberine exerts protective effects on cardiac senescence by regulating the Klotho/SIRT1 signaling pathway.

  2022cites this paper
• Toward Human Models of Cardiorenal Syndrome in vitro

  2022cites this paper
• The Klotho-FGF23-CPP axis and cardiovascular outcomes in diabetic patients with chronic limb threatening ischemia: a prospective study

  2022cites this paper
• Cardiovascular Effects of Home Dialysis Therapies: A Scientific Statement From the American Heart Association

  2022cites this paper
• The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23

  2022cites this paper
• Structural basis of FGF23 hormone signaling

  2021cites this paper
• Klotho—open questions, controversies, and future perspectives

  2021cites this paper
• Soluble α-klotho—a fibroblast growth factor 23–independent hormone

  2021cites this paper
• FGF23 and heart and vascular disease

  2021cites this paper
• FGF23—resolved issues, remaining controversies, and future questions—a clinician's perspective

  2021cites this paper
• α-Klotho gene and protein measurements in humans and their role as a clinical biomarker of disease

  2021cites this paper
• Klotho and Mesenchymal Stem Cells: A Review on Cell and Gene Therapy for Chronic Kidney Disease and Acute Kidney Disease

  2021cites this paper
• Белок клото и сердечно-сосудистая система

  2021cites this paper
• FGF23 ameliorates ischemia-reperfusion induced acute kidney injury via modulation of endothelial progenitor cells: targeting SDF-1/CXCR4 signaling

  2021cites this paper
• Protective effects of klotho on palmitate-induced podocyte injury in diabetic nephropathy

  2021cites this paper
• A Decreased Level of Soluble Klotho Can Predict Cardiovascular Death in No or Mild Abdominal Aortic Calcification Hemodialysis Patients

  2021cites this paper
• Klotho and aging phenotypes

  2021cites this paper
• Dysfunction of the Klotho-miR-30s/TRPC6 axis confers podocyte injury.

  2021cites this paper
• Excessive fibroblast growth factor 23 promotes renal fibrosis in mice with type 2 cardiorenal syndrome

  2021cites this paper
• Modeling Uremic Vasculopathy With Induced Pluripotent Stem Cell-Derived Endothelial Cells as a Drug Screening System

  2021cites this paper
• Fibroblast Growth Factor-23-Klotho Axis in Cardiorenal Syndrome: Mediators and Potential Therapeutic Targets

  2021influential citation
• Uraemic Cardiomyopathy: A Review of Current Literature

  2021cites this paper
• A systematic review and meta-analysis of murine models of uremic cardiomyopathy.

  2021cites this paper
• The intersection of Mineralocorticoid Receptor (MR) activation and the FGF23 - Klotho cascade. A Duopoly that promotes renal and cardiovascular injury.

  2021cites this paper
• FGFR4 and Klotho Polymorphisms Are Not Associated with Cardiovascular Outcomes in Chronic Kidney Disease

  2021cites this paper
• Physiologic Regulation of Systemic Klotho Levels by Renal CaSR Signaling in Response to CaSR Ligands and pHo

  2021cites this paper
• Role of lifespan-regulating genes in age-related cardiovascular disease

  2021cites this paper
• Soluble Klotho and Incident Hypertension

  2021influential citation
• [Effect of vitamin D receptor activators on serum Klotho levels in 3b-4 stages chronic кidney disease patients: a prospective randomized study].

  2021influential citation
• Klotho Protein and Cardio-Vascular System

  2021cites this paper
• The Complexity of FGF23 Effects on Cardiomyocytes in Normal and Uremic Milieu

  2021cites this paper
• Estrogen inhibits renal Na-Pi Co-transporters and improves klotho deficiency-induced acute heart failure

  2021cites this paper